Aho Fält Ursula, Zawadzki Antoni, Starck Marianne, Bohe Måns, Regnér Sara, Johnson Louis B
Department of Surgery, Skåne University Hospital - Malmö, Lund University, Sweden.
Scand J Gastroenterol. 2023 Jul-Dec;58(10):1200-1206. doi: 10.1080/00365521.2023.2212310. Epub 2023 May 18.
To explore the utilization of three-dimensional (3D) endoanal ultrasound (EAUS) for the follow-up of the anal fistula plug (AFP), describe morphological findings in postoperative 3D EAUS, and evaluate if postoperative 3D EAUS combined with clinical symptoms can predict AFP failure.
A retrospective analysis of 3D EAUS examinations performed during a single-centre study of prospectively included consecutive patients treated with the AFP between May 2006 and October 2009. Postoperative assessment by clinical examination and 3D EAUS was performed at 2 weeks, 3 months and 6-12 months ("late control"). Long-term follow-up was carried out in 2017. The 3D EAUS examinations were blinded and analysed by two observers using a protocol with defined relevant findings for different follow-up time points.
A total of 95 patients with a total of 151 AFP procedures were included. Long-term follow-up was completed in 90 (95%) patients. Inflammation at 3 months, gas in fistula and visible fistula at 3 months and at late control, were statistically significant 3D EAUS findings for AFP failure. The combination of gas in fistula and clinical finding of fluid discharge through the external fistula opening 3 months postoperatively was statistically significant ( < 0.001) for AFP failure with 91% sensitivity and 79% specificity. The positive predictive value was 91%, while the negative predictive value was 79%.
3D EAUS may be utilized for the follow-up of AFP treatment. Postoperative 3D EAUS at 3 months or later, especially if combined with clinical symptoms, can be used to predict long-term AFP failure. NCT03961984.
探讨三维(3D)腔内超声(EAUS)在肛瘘栓(AFP)随访中的应用,描述术后3D EAUS的形态学表现,并评估术后3D EAUS联合临床症状能否预测AFP治疗失败。
对2006年5月至2009年10月期间在一项单中心前瞻性研究中连续接受AFP治疗的患者进行的3D EAUS检查进行回顾性分析。术后2周、3个月和6 - 12个月(“晚期复查”)通过临床检查和3D EAUS进行评估。2017年进行长期随访。3D EAUS检查由两名观察者在不知情的情况下按照针对不同随访时间点定义了相关发现的方案进行分析。
共纳入95例患者,共进行了151次AFP手术。90例(95%)患者完成了长期随访。术后3个月的炎症、术后3个月及晚期复查时瘘管内气体及可见瘘管,是预测AFP治疗失败的具有统计学意义的3D EAUS表现。术后3个月时瘘管内气体与经外瘘口有液体流出的临床发现相结合,对AFP治疗失败具有统计学意义(<0.001),敏感性为91%,特异性为79%。阳性预测值为91%,阴性预测值为79%。
3D EAUS可用于AFP治疗的随访。术后3个月或更晚进行的3D EAUS检查,尤其是联合临床症状时,可用于预测AFP的长期治疗失败。NCT03961984。